novo nordisk glp 1 drugs Finds Medicare Patients Prefer GLP-1 Pill Over Shot for Weight Loss GLP-1 drugs may have a

Dual agonist: GLP-1 plus GIP: Tirzapeptide is a combination of GLP-1 RA and a GIP agonist that is FDA-approved for weight loss

When compared with placebo, retatrutide achieved similar changes in baseline fasting glucose levels

D., Hansen, T., & Bain, S

[DOI] [PubMed] [Google Scholar] 194.Dejgaard T.F., Knop F.K., Tarnow L., Frandsen C.S., Hansen T.S., Almdal T

Nauck et al., 2020): Compounds based on the lizard-derived exendin-4 peptide and compounds based on the human GLP-1 peptide

All doses of tirzepatide produced greater reductions in HbA1c, fasting glycemia, lipid levels, and weight loss compared to semaglutide